✦ LIBER ✦

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

✍ Scribed by Gaultney, J. G.; Franken, M. G.; Tan, S. S.; Redekop, W. K.; Huijgens, P. C.; Sonneveld, P.; Uyl-de Groot, C. A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of relapsed and refractory mul

✍ Niels W.C.J. van de Donk; Henk M. Lokhorst; Meletios Dimopoulos; Michele Cavo; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 474 KB

PSY39 REAL-WORLD COST-EFFECTIVENESS OF B

✍ Gaultney, J; Franken, M; Huijgens, PC; Sonneveld, P; Uyl-De, Groot C; Redekop, W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Treatment strategies in relapsed and ref

✍ Mohty, B; El-Cheikh, J; Yakoub-Agha, I; Avet-Loiseau, H; Moreau, P; Mohty, M 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 487 KB

PRM3 Turning the Tables to Address the R

✍ J.G. Gaultney; M.G. Franken; W.K. Redekop; P.C. Huijgens; C.A. Uyl-de Groot; P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB